Experienced in ABO Incompatibility

Jan-stephan F. Sanders

Groningen, GR, NL 
Experienced in ABO Incompatibility
Groningen, GR, NL 
OverviewLocationsClinical Research

Overview

Jan-stephan Sanders practices in Groningen, Netherlands. Sanders is rated as an Experienced expert by MediFind in the treatment of ABO Incompatibility. Their top areas of expertise are COVID-19, Granulomatosis with Polyangiitis, Vasculitis, Kidney Transplant, and Nephrectomy.

Their clinical research consists of co-authoring 105 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of ABO Incompatibility.

Locations

Groningen, GR, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Open Label Multicenter Randomized Trial Comparing Standard Immunosuppression With Tacrolimus and Mycophenolate Mofetil With a Low Exposure Tacrolimus Regimen in Combination With Everolimus in de Novo Renal Transplantation in Elderly Patient
Open Label Multicenter Randomized Trial Comparing Standard Immunosuppression With Tacrolimus and Mycophenolate Mofetil With a Low Exposure Tacrolimus Regimen in Combination With Everolimus in de Novo Renal Transplantation in Elderly Patient
Enrollment Status: Active_not_recruiting
Publish Date: May 10, 2023
Intervention Type: Drug
Study Phase: Phase 4
A Randomized Double-blind Placebo-controlled Study to Evaluate the Efficacy and Safety of Cinryze® (C1 Esterase Inhibitor [Human]) for the Treatment of Acute Antibody-mediated Rejection in Kidney Transplant Patients
A Randomized Double-blind Placebo-controlled Study to Evaluate the Efficacy and Safety of Cinryze® (C1 Esterase Inhibitor [Human]) for the Treatment of Acute Antibody-mediated Rejection in Kidney Transplant Patients
Enrollment Status: Terminated
Publish Date: July 13, 2020
Intervention Type: Drug, Biological
Study Phase: Phase 3
View 1 Less Clinical Trial

105 Total Publications

Memory B-Cell Assay Uncovers Prior HLA Sensitisation in Transplant Candidates With Prior Exposure to Non-Self HLA.
Memory B-Cell Assay Uncovers Prior HLA Sensitisation in Transplant Candidates With Prior Exposure to Non-Self HLA.
Journal: HLA
Published: May 14, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Sanders's expertise for a condition
ConditionClose
    View All 19 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile